Data / Research funding / Eczema / Atopic Dermatitis
Eczema / Atopic Dermatitis: 117 NIH awards ($190.1M) to 48 organizations
117 NIH awards ($190.1M) in the NIH spending category Eczema / Atopic Dermatitis, to 48 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
117 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $27,224,161 | April 9, 2020 | March 31, 2027 | LEUNG, DONALD YM | reporter.nih.gov |
| New Horizons in the Prevention and Treatment of Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $25,961,502 | April 4, 2024 | February 28, 2031 | WOOD, ROBERT A | reporter.nih.gov |
| Systems Biology of Early Atopy (SUNBEAM) Analysis and Bioinformatics Center | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $7,049,932 | December 8, 2022 | November 30, 2028 | BUNYAVANICH, SUPINDA | reporter.nih.gov |
| SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $6,503,998 | August 14, 2020 | May 31, 2027 | NADEAU, KARI C. | reporter.nih.gov |
| Skin microbes and development of allergic disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $5,176,858 | September 5, 2025 | August 31, 2029 | GALLO, RICHARD L | reporter.nih.gov |
| SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $3,482,713 | August 14, 2020 | January 13, 2023 | NADEAU, KARI C. | reporter.nih.gov |
| Regulation of IgE and Atopic Itch | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,243,540 | September 19, 2022 | July 31, 2027 | CONROY, MICHELLE E | reporter.nih.gov |
| Staphylococcus aureus induced itch and neuro-immune signaling in skin infections | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,933,850 | September 19, 2022 | July 31, 2027 | CHIU, ISAAC MING-CHENG | reporter.nih.gov |
| SUNBEAM Birth Cohort Supplement | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,806,605 | September 6, 2024 | June 30, 2029 | SEIBOLD, MAX A | reporter.nih.gov |
| Cholesterol metabolites coordinate skin barrier immunity centered on innate dermal gammadelta T cells programmed to produce IL-17 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,805,911 | November 1, 2021 | October 31, 2026 | KANG, JOONSOO | reporter.nih.gov |
| Elucidating the Role of Regulatory T cells in Establishing and Maintaining a Th2 Niche in Skin | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,768,552 | July 10, 2020 | June 30, 2025 | ROSENBLUM, MICHAEL DAVID | reporter.nih.gov |
| Dupilumab in the Treatment of Pediatric Alopecia Areata | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,738,616 | May 15, 2024 | April 30, 2029 | GUTTMAN, EMMA | reporter.nih.gov |
| New approaches to safety monitoring of novel systemic treatments for atopic dermatitis in clinical practice and underrepresented populations | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,677,568 | February 1, 2022 | December 31, 2026 | SCHNEEWEISS, SEBASTIAN G. | reporter.nih.gov |
| Atopic dermatitis in an urban adult population: identifying the role of social and environmental factors | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,644,701 | July 1, 2022 | April 30, 2027 | TAKESHITA, JUNKO | reporter.nih.gov |
| Genetic and microbial modifiers of Atopic Dermatitis (AD): Mechanisms of increased AD severity in patients with the R576 polymorphism in IL-4Ra and impact of S aureus skin decolonization on AD | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,616,514 | April 1, 2020 | March 31, 2027 | GEHA, RAIF SALIM | reporter.nih.gov |
| Mechanisms for initiation of food allergy early in life | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,583,439 | July 1, 2020 | June 30, 2026 | COOK-MILLS, JOAN M | reporter.nih.gov |
| Regulatory Variants in Human Skin Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,487,678 | May 1, 2020 | May 31, 2030 | KHAVARI, PAUL | reporter.nih.gov |
| Defining the role of IL-18 in atopic dermatitis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,442,278 | April 10, 2023 | March 31, 2028 | VAN DYKEN, STEVEN | reporter.nih.gov |
| Microbiome Function in Atopic Dermatitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,356,653 | May 1, 2020 | April 30, 2027 | GALLO, RICHARD L | reporter.nih.gov |
| Effect of Th2-type microenvironment on CD8 TRM-mediated protection from infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,345,520 | May 19, 2022 | April 30, 2027 | BROMLEY, SHANNON K | reporter.nih.gov |
| Mechanisms of enhanced food allergy by S. aureus skin colonization in Atopic Dermatitis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,339,515 | March 22, 2023 | February 29, 2028 | GEHA, RAIF SALIM | reporter.nih.gov |
| Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD Patients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,310,254 | April 6, 2020 | March 31, 2027 | BECK, LISA ANN | reporter.nih.gov |
| Structural and functional principles of activation and regulation of the transient receptor potential channel TRPV3. | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,280,519 | February 1, 2022 | January 31, 2027 | SOBOLEVSKY, ALEXANDER | reporter.nih.gov |
| Microbial regulation of the keratinocyte AHR | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,197,247 | April 1, 2022 | March 31, 2027 | GRICE, ELIZABETH ANNE | reporter.nih.gov |
| Childhood Asthma in Urban Settings | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,163,187 | April 15, 2021 | March 31, 2028 | BUSSE, PAULA J | reporter.nih.gov |
| Mechanistic elucidation of pathogenic CBM complex mutations associated with atopic disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,100,471 | July 5, 2023 | June 30, 2028 | SNOW, ANDREW L | reporter.nih.gov |
| Sodium in the Skin and Atopic Dermatitis: The SIS-AD Study | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $2,019,410 | September 22, 2023 | August 31, 2028 | ABUABARA, KATRINA ELAINE | reporter.nih.gov |
| Natural Killer Cell Regulation of Skin Inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,984,860 | February 2, 2022 | February 28, 2027 | KIM, BRIAN | reporter.nih.gov |
| IND Enabling Studies for the Development of Pruritus Therapeutic PRA-523 | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $1,972,827 | July 1, 2022 | August 31, 2025 | PIPPIN, DOUGLAS ANTHONY | reporter.nih.gov |
| Novel Roles of GRK2 and beta-arrestin2 on mast cell-mediated allergy and Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,940,347 | May 14, 2020 | April 30, 2026 | ALI, HYDAR | reporter.nih.gov |
| A Community-based Assessment of Skin Care, Allergies, and Eczema: The CASCADE Trial | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,840,538 | April 1, 2018 | February 28, 2025 | SIMPSON, ERIC L | reporter.nih.gov |
| Unraveling the Role of Langerhans Cells in Itch | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $1,826,181 | September 1, 2025 | August 31, 2028 | AKIYAMA, TASUKU | reporter.nih.gov |
| Epidemiology of multimorbid pediatric atopic and airway diseases and the impact of prenatal maternal environmental exposures and placental epigenetics | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $1,677,190 | September 1, 2023 | May 31, 2025 | STRAUGHEN, JENNIFER K. | reporter.nih.gov |
| ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,648,190 | April 10, 2020 | March 31, 2027 | LEUNG, DONALD YM | reporter.nih.gov |
| Controlled Release Eczema Bandage (CREB) | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $1,626,559 | August 1, 2025 | April 15, 2026 | SINGHAL, AJ | reporter.nih.gov |
| Integrin receptor: A connecting link between skin and peripheral sensing neurons in atopic dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,511,096 | July 1, 2021 | June 30, 2026 | MISHRA, SANTOSH K. | reporter.nih.gov |
| Role and Regulation of TSLP in Childhood Allergic Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,477,913 | December 6, 2017 | November 30, 2023 | KHURANA HERSHEY, GURJIT K. | reporter.nih.gov |
| Atopic dermatitis: mechanisms of disease progression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,439,129 | April 20, 2020 | March 31, 2027 | KHURANA HERSHEY, GURJIT K. | reporter.nih.gov |
| Sphingolipid Biosynthesis in the Healthy and Diseased Epidermal Barrier | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,369,640 | July 1, 2024 | June 30, 2029 | WATTENBERG, BRIAN W. | reporter.nih.gov |
| Developing a Molecular Map of Atopic Dermatitis Across Ethnicity and Severity Subtypes. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,364,977 | April 13, 2020 | March 31, 2027 | GUTTMAN, EMMA | reporter.nih.gov |
| Conflict and Cooperation between AMP Species on the skin | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,346,028 | July 1, 2019 | April 30, 2025 | GALLO, RICHARD L | reporter.nih.gov |
| Team-Based Connected Health to Improve Access and Outcomes in Atopic Dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,338,555 | February 5, 2019 | July 14, 2023 | ARMSTRONG, APRIL W | reporter.nih.gov |
| Role of NK-1 receptors in descending modulation and ascending transmission of itch | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,318,932 | August 5, 2020 | July 31, 2025 | CARSTENS, EARL E | reporter.nih.gov |
| Staphylococcal protease-mediated epithelial barrier perturbation and allergen sensitization | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,290,735 | January 18, 2024 | November 30, 2028 | PARK, JIN MO | reporter.nih.gov |
| Neuronal MRGPR signaling in itch and allergic skin inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,199,694 | December 6, 2023 | November 30, 2028 | LERNER, ETHAN A | reporter.nih.gov |
| Fibroblast dysregulation promotes dermal eosinophilic/Th2 inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,193,443 | September 21, 2023 | August 31, 2028 | GRAVES, DANA T | reporter.nih.gov |
| Dynamic interplay between IL-36 and IL-1 in inflammation and infections | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,188,750 | June 1, 2023 | May 31, 2028 | JENSEN, LISELOTTE E | reporter.nih.gov |
| Deciphering the Piezo2-Merkel cell signaling mechanisms in itch | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $1,118,598 | December 1, 2023 | July 31, 2025 | HU, HONGZHEN | reporter.nih.gov |
| Deciphering the Piezo2-Merkel cell signaling mechanisms in itch | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,018,098 | August 1, 2020 | August 2, 2023 | HU, HONGZHEN | reporter.nih.gov |
| Cytokine regulation of skin barrier function | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $954,446 | February 15, 2012 | January 31, 2024 | KAPLAN, MARK H | reporter.nih.gov |
| Atopic Dermatitis and High Resolution HLA | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $866,713 | September 1, 2017 | November 30, 2023 | MARGOLIS, DAVID | reporter.nih.gov |
| Molecular mechanisms of staphylococcal modulation of skin homeostasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $852,068 | June 1, 2024 | October 14, 2024 | OH, JULIA | reporter.nih.gov |
| Decoding mechanisms of early life inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $797,735 | June 11, 2025 | May 31, 2030 | NAIK, SHRUTI | reporter.nih.gov |
| Remote Exposome Monitoring for Autoimmune Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $795,574 | September 18, 2023 | August 31, 2026 | LIAO, WILSON | reporter.nih.gov |
| TWEAK and Skin Inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $776,160 | July 18, 2018 | October 31, 2023 | CROFT, MICHAEL | reporter.nih.gov |
| Impact of Pediatric Atopic Dermatitis on Neurocognitive Function | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $775,851 | November 1, 2021 | March 31, 2026 | WAN, JOY | reporter.nih.gov |
| University of Michigan MHWFAC CoFar CMC Center Application | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $760,000 | March 15, 2024 | February 28, 2031 | BAKER, JAMES R. | reporter.nih.gov |
| Mechanisms of control of allergic skin inflammation by T regulatory cells | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $716,281 | July 24, 2025 | June 30, 2030 | GEHA, RAIF SALIM | reporter.nih.gov |
| Use of specific JAK inhibition on inflammatory skin and scalp diseases in Down syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $708,517 | July 3, 2024 | April 30, 2026 | GUTTMAN, EMMA | reporter.nih.gov |
| Parent-directed remote identification and severity assessments enabling decentralized trials in atopic dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $705,504 | February 16, 2024 | January 31, 2027 | SIMPSON, ERIC L | reporter.nih.gov |
| National Jewish Health CoFAR Clinical Research Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $704,994 | March 2, 2017 | February 29, 2024 | LEUNG, DONALD YM | reporter.nih.gov |
| Molecular mechanisms of staphylococcal modulation of skin homeostasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $653,018 | February 10, 2024 | January 31, 2030 | OH, JULIA | reporter.nih.gov |
| Defining and treating genetic abnormalities in psoriasis/atopic dermatitis-overlap dermatoses | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $628,968 | June 20, 2025 | April 30, 2030 | CHO, RAYMOND JAIHYUN | reporter.nih.gov |
| Elucidating the Role of Cutaneous Environmental Factors in the Development of Allergic Disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $584,820 | July 1, 2023 | June 30, 2028 | EISENSTEIN, ANNA | reporter.nih.gov |
| Interplay of Regulatory Innate T Cells and Pathogenic T Clonotypes In Dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $565,627 | April 1, 2017 | March 31, 2022 | KANG, JOONSOO | reporter.nih.gov |
| Elucidating the role of type 2 immunity in skin homeostasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $532,980 | September 24, 2019 | May 31, 2025 | RICARDO-GONZALEZ, ROBERTO RAFAEL | reporter.nih.gov |
| Interleukin-31 at the neuroimmune interface of pruritus and dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $532,494 | September 25, 2019 | April 30, 2025 | FASSETT, MARLYS S | reporter.nih.gov |
| Racial Differences in Biomarkers and Therapeutic Targets for Chronic Itch | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $531,240 | July 15, 2021 | March 15, 2024 | KWATRA, SHAWN GAURAV | reporter.nih.gov |
| T-cell plasticity mediating treatment resistance and side effects in atopic dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $528,558 | September 1, 2025 | August 31, 2030 | BRUNNER, PATRICK | reporter.nih.gov |
| Insights into skin barrier function: In silico and experimental studies of healthy and diseased stratum corneum lipid models | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $523,306 | August 10, 2018 | June 30, 2025 | LAIBINIS, PAUL E | reporter.nih.gov |
| Investigation of Filaggrin Gene Mutations among Latinx patients with Atopic Dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $518,127 | August 17, 2023 | June 30, 2028 | CHIESA FUXENCH, ZELMA CHARLOTTE | reporter.nih.gov |
| Role of nociceptive sensory neuron/mast cell interactions in cutaneous allergic inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $481,734 | June 1, 2017 | May 31, 2023 | GALLI, STEPHEN JOSEPH | reporter.nih.gov |
| Natural Killer Cell Regulation of Skin Inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $480,292 | March 1, 2021 | February 28, 2022 | KIM, BRIAN | reporter.nih.gov |
| Role of B. infantis in Development of Atopic Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $476,523 | June 16, 2021 | May 31, 2024 | JARVINEN-SEPPO, KIRSI | reporter.nih.gov |
| MNA Delivery of Neurokinin 1 Receptor Antagonists to Treat Atopic Dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $472,668 | August 1, 2017 | May 31, 2022 | FALO, LOUIS D | reporter.nih.gov |
| Epidemiology of multimorbid pediatric atopic and airway diseases and the impact of prenatal maternal environmental exposures and placental epigenetics | NIH | Office of the Director, National Institutes of Health | 2025 | $466,781 | September 1, 2023 | May 31, 2030 | STRAUGHEN, JENNIFER K. | reporter.nih.gov |
| The Role of IL-33 in Chronic Itch | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $460,468 | September 24, 2021 | August 31, 2024 | KIM, BRIAN | reporter.nih.gov |
| Early life dysbiosis, and skin barrier function | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $451,254 | November 17, 2023 | October 31, 2026 | GHOSH, DEBAJYOTI | reporter.nih.gov |
| Modulation of Chronic Th2 inflammation by the CCR8 Receptor-Ligand Pathway | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $416,850 | November 21, 2016 | February 28, 2022 | ISLAM, SABINA A | reporter.nih.gov |
| DIVERSITY OF HUMAN MILK OLIGOSACCHARIDE METABOLIZING GENES IN TWO INFANT COHORTS | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $408,740 | December 6, 2021 | November 30, 2025 | KLEPAC-CERAJ, VANJA | reporter.nih.gov |
| MMP13 expression and function in allergic inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $407,286 | November 22, 2016 | October 31, 2022 | PARK, JIN MO | reporter.nih.gov |
| Role of healthy skin molecular phenotype in the switch to specific skin diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $399,812 | September 23, 2022 | August 31, 2025 | BUDUNOVA, IRINA | reporter.nih.gov |
| Chemoproteomics and Lipidomics for Identifying Dysregulated Enzymes and Lipids in Cutaneous Disorders. | NIH | Office of the Director, National Institutes of Health | 2025 | $397,709 | August 11, 2025 | July 31, 2030 | KOLAR, MATTHEW JOHN | reporter.nih.gov |
| Hormones in allergic disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $392,333 | December 7, 2016 | November 30, 2022 | BERDNIKOVS, SERGEJS | reporter.nih.gov |
| Identification of therapeutic small molecules for treatment of skin fibrosis by modulating epidermal pro-inflammatory signaling | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $387,200 | August 1, 2022 | June 30, 2024 | HONG, SEOK JONG | reporter.nih.gov |
| IL-36 activity during skin infections | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $383,570 | September 18, 2023 | August 31, 2025 | JENSEN, LISELOTTE E | reporter.nih.gov |
| Pathologic consequences of epidermal lipase deficiencies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $378,340 | February 20, 2024 | January 31, 2026 | TURNER, MATTHEW J | reporter.nih.gov |
| Targeted therapeutic modulation of inflammatory cytokines through manipulation of noncoding RNA regulation of innate immunity in atopic dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $370,214 | September 19, 2019 | August 31, 2023 | WANG, KEVIN CHUN-KAI | reporter.nih.gov |
| Trim32 regulation of PKC-zeta in atopic dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $358,813 | April 3, 2017 | January 31, 2023 | LIU, YUANGANG | reporter.nih.gov |
| Optimizing Equitable Peanut Allergy Prevention among Infants at High Risk of Peanut Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $357,955 | August 20, 2024 | July 31, 2028 | FLOM, JULIE | reporter.nih.gov |
| Social, environmental, and epigenetic drivers of atopic dermatitis disease course | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $350,222 | August 3, 2018 | May 31, 2024 | ABUABARA, KATRINA ELAINE | reporter.nih.gov |
| African-Americans with Atopic Dermatitis: Skin Barrier and Immune | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $344,342 | February 18, 2016 | November 30, 2021 | MARGOLIS, DAVID | reporter.nih.gov |
| Contributions of gastrointestinal Staphylococcus aureus and other gut microbiota to pediatric atopic dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $344,010 | April 1, 2024 | March 31, 2029 | KARAGOUNIS, THEODORA KATERINA | reporter.nih.gov |
| Investigating single-T cell atopic gene networks in Asian and Hispanic genetic backgrounds | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $343,904 | September 20, 2024 | August 31, 2025 | CHO, RAYMOND JAIHYUN | reporter.nih.gov |
| Racial Differences in Biomarkers and Therapeutic Targets for Chronic Itch | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $342,144 | May 1, 2024 | August 31, 2027 | KWATRA, SHAWN GAURAV | reporter.nih.gov |
| Circadian Rhythms of Skin Barrier, Pruritus and Inflammation in Atopic Dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $336,960 | September 25, 2019 | October 24, 2023 | FISHBEIN, ANNA B | reporter.nih.gov |
| Role of Staphylococcus aureus and Host immunity in Allergic Skin Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $332,904 | July 1, 2017 | June 30, 2023 | NUNEZ, GABRIEL | reporter.nih.gov |
| Associations between Perfluoroalkyl Substances (PFAS) Exposure and Aeroallergen Sensitization among Infants at High-Risk for Developing Asthma | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $322,632 | January 1, 2024 | December 31, 2028 | JACKSON-BROWNE, MEDINA SAMIRA | reporter.nih.gov |
| Development of a molecular-level skin condition diagnostic for precision medicine | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $275,764 | September 20, 2022 | August 31, 2024 | SHERROD, STACY D. | reporter.nih.gov |
| Novel 5-HT7 Antagonists for the Treatment of Pruritus | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $275,544 | July 1, 2022 | August 31, 2023 | PIPPIN, DOUGLAS ANTHONY | reporter.nih.gov |
| Microbiome-Balancing Wraps for Managing Eczema | NIH | National Center for Complementary & Integrative Health | 2021 | $253,024 | August 1, 2021 | April 30, 2023 | PARITALA, HANUMANTHARAO | reporter.nih.gov |
| Understanding the role of S. aureus agr virulence in atopic dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $252,525 | June 1, 2022 | May 31, 2027 | MATSUMOTO, MASANORI | reporter.nih.gov |
| System for documenting and tracking skin lesions | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 | $252,388 | July 1, 2022 | March 31, 2024 | TASHAYYOD, DAVOOD | reporter.nih.gov |
| Unraveling Epigenetic and Transcription Control in Understudied Skin Types | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $250,396 | September 5, 2025 | August 31, 2027 | EZHKOVA, ELENA | reporter.nih.gov |
| Skin probiotics to treat atopic dermatitis | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $249,935 | July 1, 2023 | June 30, 2024 | ZARGAR, AMIN | reporter.nih.gov |
| Investigating the role of skin and gut microbiome in the onset of atopic dermatitis in infants | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $249,000 | April 1, 2024 | July 31, 2028 | SHEN, ZEYANG | reporter.nih.gov |
| Personalized Prediction of Atopic Dermatitis Disease Course Across Diverse Settings | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $243,950 | September 19, 2025 | June 30, 2028 | ABUABARA, KATRINA ELAINE | reporter.nih.gov |
| Staphylococcus aureus induced itch and neuro-immune signaling in skin inflammation and atopic dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $200,276 | August 1, 2024 | July 31, 2027 | DENG, LIWEN | reporter.nih.gov |
| Systemic Treatments and Outcomes for Pediatric Atopic Dermatitis: Setting the Stage for Comparative Effectiveness Research | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $170,490 | July 19, 2024 | June 30, 2026 | WAN, JOY | reporter.nih.gov |
| Atopic dermatitis in childhood and risk of early cardiovascular disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $161,500 | April 5, 2021 | March 31, 2024 | ABUABARA, KATRINA ELAINE | reporter.nih.gov |
| Incidence of atopy and childhood infections in uninfected term newborns with perinatal antibiotic exposure | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $156,825 | August 1, 2017 | July 31, 2022 | MUKHOPADHYAY, SAGORI | reporter.nih.gov |
| Understanding the role of S. aureus agr virulence in atopic dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $110,811 | June 1, 2022 | August 10, 2023 | MATSUMOTO, MASANORI | reporter.nih.gov |
| Mechanisms of Longitudinal Microbial Colonization in Pediatric Atopic Dermatitis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $84,573 | January 1, 2024 | October 31, 2026 | DAHAL, ARYA | reporter.nih.gov |
| Impact of Pediatric Atopic Dermatitis on Neurocognitive Function | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $81,945 | April 1, 2021 | October 31, 2021 | WAN, JOY | reporter.nih.gov |
| Breaking down barriers: defining the role of EphA2 in building epidermal tight junctions in atopic dermatitis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $62,875 | August 1, 2021 | July 31, 2022 | PEREZ WHITE, BETHANY E | reporter.nih.gov |
| Epithelial Regulation of Chronic Itch | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $51,036 | July 1, 2020 | June 30, 2022 | TRIER, ANNA MEREDITH | reporter.nih.gov |
| Developmental control of inflammatory memory in atopic dermatitis-like skin disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $44,020 | January 1, 2026 | December 31, 2028 | OLIVER, ISABELLE | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 62 | $57,124,041 | 0 | $0 |
| 2024 | 60 | $49,941,475 | 0 | $0 |
| 2023 | 52 | $27,390,033 | 0 | $0 |
| 2022 | 50 | $26,746,619 | 0 | $0 |
| 2021 | 50 | $28,856,822 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.